Market
Will the mRNA cancer vaccine cost remain 300,000 rubles or less by end of 2025?
2
Russia•Ministry of Health•Gamaleya National Research Center•Andrey Kaprin•Radiology Medical Research Center•Russian Ministry of Health•Russian
Resolution / Starting Odds
Yes • 50%
No • 50%
Official pricing announcements from the Russian government or health authorities
Story
Russia to Launch Free mRNA Cancer Vaccine in 2025, Aims for 75-80% Tumor Reduction
Dec 17, 2024, 09:02 PM
Russia's Ministry of Health has announced the development of a personalized cancer vaccine using mRNA technology, set to be distributed to patients for free starting in early 2025. The vaccine, developed by the Gamaleya National Research Center, is designed to treat cancer patients rather than prevent cancer in the general public. It aims to suppress tumor growth and prevent the spread of cancer, with early trials showing the ability to reduce tumor size by 75-80% and slow tumor progression. Andrey Kaprin, the General Director of the Radiology Medical Research Center of the Russian Ministry of Health, stated that the vaccine will be personalized for each patient's specific cancer type. The Russian government has given the green light for mass production of the vaccine, which is expected to cost the state 300,000 rubles per dose.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
301,000 to 350,000 rubles • 25%
Exactly 300,000 rubles • 25%
Less than 300,000 rubles • 25%
More than 350,000 rubles • 25%
80-90% efficacy • 25%
Above 90% efficacy • 25%
Below 70% efficacy • 25%
70-79% efficacy • 25%
Less than 10,000 • 25%
More than 100,000 • 25%
50,001 to 100,000 • 25%
10,000 to 50,000 • 25%
Less than 10,000 • 25%
More than 100,000 • 25%
50,001 to 100,000 • 25%
10,000 to 50,000 • 25%
U.S. FDA Approval • 25%
EU Approval • 25%
WHO Recognition • 25%
No International Recognition • 25%